FALL FELLOWS

Recommendations

Info

2016 FALL FELLOWS COURSES December 10-14, 2016 • Las Vegas, Nevada THE SMART SOLUTION FOR SEVERE CALCIUM VISIT CSI’S BOOTH TO LEARN MORE ABOUT ORBITAL ATHERECTOMY WHEN YOU SEE CALCIUM, THINK DIAMONDBACK. Visit whyorbital.com to find out more. Indication: The Diamondback 360 ® Coronary Orbital Atherectomy System (OAS) is a percutaneous orbital atherectomy system indicated to facilitate stent delivery in patients with coronary artery disease (CAD) who are acceptable candidates for PTCA or stenting due to de novo, severely calcified coronary artery lesions. Contraindications: The OAS is contraindicated when the ViperWire ® guide wire cannot pass across the coronary lesion or the target lesion is within a bypass graft or stent. The OAS is contraindicated when the patient is not an appropriate candidate for bypass surgery, angioplasty, or atherectomy therapy, or has angiographic evidence of thrombus, or has only one open vessel, or has angiographic evidence of significant dissection at the treatment site and for women who are pregnant or children. Warnings/Precautions: Performing treatment in excessively tortuous vessels or bifurcations may result in vessel damage; The OAS was only evaluated in severely calcified lesions, a temporary pacing lead may be necessary when treating lesions in the right coronary and circumflex arteries; On-site surgical back-up should be included as a clinical consideration; Use in patients with an ejection fraction (EF) of less than 25% has not been evaluated. See the instructions for use before performing Diamondback 360 coronary orbital atherectomy procedures for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential adverse events. Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. CSI and Diamondback 360 are registered trademarks of Cardiovascular Systems, Inc. ©2016 Cardiovascular Systems, Inc. EN-3444.A 0916 877-CSI-0360 // WWW.WHYORBITAL.COM 2 FINAL PROGRAM
Preparing the FUTURE of Interventional Cardiology COMMERCIAL SUPPORT SCAI thanks the following companies for their generous educational grant support of the SCAI 2016 Fall Fellows Courses while taking sole responsibility for all content developed and disseminated through this event. Gold Supporters Boston Scientific Medtronic Silver Supporter Abbott Bronze Supporters Abiomed Cook Medical Cordis, A Cardinal Health Company Edwards Lifesciences St. Jude Medical Terumo Interventional Systems SCAI also thanks the following companies for support of: • Boston Scientific: Charging Stations and Registration Lanyards • Medtronic: SCAI 2016 Fall Fellows Welcome Reception • St. Jude Medical: Heart Dissection Program FALL FELLOWS 2016 COURSES General Information ......................................... 4-7 • Program Chairs, Faculty .................................................... • Course Overview, Learning Objectives ................................ 4 5 • Target Audience, Attendance Certificates, Wi-Fi Password Content Validation Statement, Exhibit Hall Passport ............ • Locations & Hours: Registration Desk, Speaker Ready Room, Exhibit Hall, General Sessions, Breakout Sessions, Satellite Symposia ............................. Adult Course Agenda ...................................... Congenital / Structural Heart Disease Course Agenda ........................................................ Exhibit Hall, Exhibitor Information ................ Satellite Symposia Information ..................... 6 6-7 8-13 14-19 20-21 22-23 SCAI 2016 FALL FELLOWS COURSES December 10-14, 2016 • Las Vegas, Nevada 3
Page 1: Preparing the FUTURE of Interventio
Page 5 and 6: Preparing the FUTURE of Interventio
Page 23 and 24: SATELLITE SYMPOSIA Monday, December

FALL FELLOWS

Create successful ePaper yourself

Delete template?

Save as template?